<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01176734</url>
  </required_header>
  <id_info>
    <org_study_id>cMPsTIN01</org_study_id>
    <nct_id>NCT01176734</nct_id>
  </id_info>
  <brief_title>The Treatment of Tinnitus With Transcutaneous Non-invasive Vagus Nerve Stimulation</brief_title>
  <official_title>The Treatment of Tinnitus With Transcutaneous Non-invasive Vagus Nerve stimulation-a Controlled Randomized Pilot Study Assessing Safety, Compatibility and Clinical Performance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>cerbomed GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>cerbomed GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The t-VNS STv3 device is a non-invasive, transcutaneous neurostimulator for influencing the
      afferent branches of the nervus vagus around the human ear. The clinical trial is designed as
      a a pilot study addressing the treatment of tinnitus with transcutaneous vagus nerve
      stimulation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety, feasibility and effectiveness of t-VNS® stimulation</measure>
    <time_frame>24 weeks</time_frame>
    <description>Determination of safety, feasibility and effectiveness of t-VNS measured by tinnitus score according to Goebel and Hiller between baseline and week 24</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Tinnitus</condition>
  <arm_group>
    <arm_group_label>active t-VNS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>active t-VNS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tVNS-Device</intervention_name>
    <description>Active treatment with the t-VNS device.</description>
    <arm_group_label>active t-VNS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic tinnitus defined as a tinnitus over more than six months

          -  ≥31 points in the tinnitus questionnaire according to Goebel and Hiller

          -  Written informed consent

          -  Both gender, aged from 18 -75 years

          -  If the subject takes psychoactive medication (e.g antidepressants, anticonvulsives)
             therapy must be stable for at least 10 days. If a treatment with neuroleptics is
             necessary, only olanzapine and quetiapine should be used. The therapy should be
             constantly though a necessary change in medication is no reason for exclusion of the
             subject.

        Exclusion Criteria:

          -  Objective tinnitus

          -  Participating in other tinnitus treatments within 3 months before study start

          -  Missing informed consent

          -  Pregnancy

          -  Bronchial asthma in medical history

          -  Clinically relevant internistic, neurological or psychiatric diseases

          -  Abuse of drugs or alcohol until 12 weeks before enrollment in the study

          -  Indications of structural impairment of the basal ganglia or the brain stem

          -  Active implants (e.g. cochlea implants, VNS, pacemaker)

          -  Constant all-day use of hearing instruments or noisers on the left the part-time use
             in special situations (e.g. watching TV is no exclusion criteria

          -  All dermatologic and infectious diseases which affect the area around the pinna and
             the ear canal

          -  Severe malformation of the pinna

          -  Other circumstances that in the opinion of the investigator might be an obstacle for
             enrolling the subject
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Berthold Langguth, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Regensburg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinik für Psychiatrie und Psychotherapie Bezirksklinikum Regensburg Universitätsstr. 84 93053 Regensburg E-mail: Berthold.Langguth@medbo.de Tel.: 0941 941 2099 Fax.: 0941 941 2025 Dr. med Michael Landgrebe, Klinik für Psychiatrie und Psychotherapie Bezir</name>
      <address>
        <city>Regensburg</city>
        <state>Bavaria</state>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2010</study_first_submitted>
  <study_first_submitted_qc>August 5, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2010</study_first_posted>
  <last_update_submitted>April 29, 2013</last_update_submitted>
  <last_update_submitted_qc>April 29, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 30, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pulsatile Tinnitus</keyword>
  <keyword>Ringing-Buzzing-Tinnitus</keyword>
  <keyword>Spontaneous Oto-Acoustic Emission Tinnitus</keyword>
  <keyword>Tensor Palatini Induced Tinnitus</keyword>
  <keyword>Tensor Tympani Induced Tinnitus</keyword>
  <keyword>Tinnitus of Vascular Origin</keyword>
  <keyword>Tinnitus, Clicking</keyword>
  <keyword>Tinnitus, Leudet</keyword>
  <keyword>Tinnitus, Leudet's</keyword>
  <keyword>Tinnitus, Noise Induced</keyword>
  <keyword>Tinnitus, Objective</keyword>
  <keyword>Tinnitus, Spontaneous Oto-Acoustic Emission</keyword>
  <keyword>Tinnitus, Subjective</keyword>
  <keyword>Tinnitus, Tensor Palatini Induced</keyword>
  <keyword>Tinnitus, Tensor Tympani Induced</keyword>
  <keyword>Vascular Origin Tinnitus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tinnitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

